Page 42 - 南京医科大学自然版

第44卷第12期
·1656 · 南 京 医 科 大 学 学 报 2024年12月

［5］ MATSUO T，DAT L E T，KOMATSU M，et al. Early sensitivity to ROS via Tpl2⁃MEK1/2⁃ERK1/2 pathway［J］.
growth response 4 is involved in cell proliferation of small Cell Death Dis，2022，13（11）：942
cell lung cancer through transcriptional activation of its ［14］SUN Y T，DONG Y T，LIU X J，et al. Blockade of STAT3/
downstream genes［J］. PLoS One，2014，9（11）：e113606 IL⁃4 overcomes EGFR T790M⁃Cis⁃L792F⁃induced resis⁃
［6］ LI F，XU Y，LIU R L. SAMD5 mRNA was overexpressed tance to osimertinib via suppressing M2 macrophages po⁃
in prostate cancer and can predict biochemical recur⁃ larization［J］. EBioMedicine，2022，83：104200
rence after radical prostatectomy［J］. Int Urol Nephrol， ［15］ZHANG C，DU F H，WANG R X，et al. TSPAN6 reinforces
2019，51（3）：443-451 the malignant progression of glioblastoma via interacting
［7］ ZHANG L，CHEN W Z，SHI Z K，et al. PARP14 corre⁃ with CDK5RAP3 and regulating STAT3 signaling path⁃
lates with GBM proliferation and poor prognosis by elevat⁃ way［J］. Int J Biol Sci，2024，20（7）：2440-2453
ing expression of SAMD/SAMD9L［J］. Ir J Med Sci，2024， ［16］LI Q，LUO H，DAI F Q，et al. SAMD9 promotes postopera⁃

193（2）：585-593 tive recurrence of esophageal squamous cell carcinoma by
［8］ SERWE G，KACHANER D，GAGNON J，et al. CNK2 pro⁃ stimulating MYH9⁃mediated GSK3β / β ⁃catenin signal⁃
motes cancer cell motility by mediating ARF6 activation ing［J］. Adv Sci，2023，10（11）：e2203573
downstream of AXL signalling［J］. Nat Commun，2023，14 ［17］PAN Q W，MENG X，LI J X，et al. CircSAMD11 facili⁃
（1）：3560 tates progression of cervical cancer via regulating miR ⁃
［9］ YOO W，KIM S，NOH K. SAMD13 serves as a useful prog⁃ 503/SOX4 axis through Wnt/β⁃catenin pathway［J］. Clin
nostic biomarker for hepatocellular carcinoma［J］. Eur J Exp Pharmacol Physiol，2022，49（1）：175-187
Med Res，2023，28（1）：514 ［18］LU G H，ZHAO H M，LIU Z Y，et al. LncRNA SAMD12⁃
［10］LI R，YAN X J，ZHONG W H，et al. Stratifin promotes the AS1 promotes the progression of gastric cancer via DN⁃
malignant progression of HCC via binding and hyperacti⁃ MT1/p53 axis［J］. Arch Med Res，2021，52（7）：683-691
vating AKT signaling［J］. Cancer Lett，2024，592：216761 ［19］WANG J，ZHOU Y，GU C Y，et al. LncRNA SAMD12⁃
［11］WANG D，YAN K，YU H X，et al. Fimepinostat impairs AS1 suppresses proliferation and migration of hepatocellu⁃
NF⁃κB and PI3K/AKT signaling and enhances gemcitabine lar carcinoma via p53 signaling pathway［J］. J Oncol，
efficacy in H3.3K27M⁃diffuse intrinsic pontine glioma［J］. 2022，2022：9096365
Cancer Res，2024，84（4）：598-615 ［20］WEN X M，JIAO L D，TAN H. MAPK/ERK pathway as a
［12］HE Z Q，ZHONG Y H，LV T R，et al. PP4R1 promotes gly⁃ central regulator in vertebrate organ regeneration［J］. Int
colysis and gallbladder cancer progression through facili⁃ J Mol Sci，2022，23（3）：1464
tating ERK1/2 mediated PKM2 nuclear translocation［J］. ［21］MARTIN⁃VEGA A，COBB M H. Navigating the ERK1/2
Cancer Lett，2024，586：216677 MAPK cascade［J］. Biomolecules，2023，13（10）：1555
［13］WEI C，ZHANG X Y，PENG D Z，et al. LncRNA HOXA11⁃ ［收稿日期］ 2024-09-20
AS promotes glioma malignant phenotypes and reduces its （本文编辑：戴王娟）